Patients News | pharmaphorum

News

NICE backs wider tumour profiling use in early breast cancer

Three tests that can be used to profile tumours in people with breast cancer and predict whether they will respond to chemotherapy have been cleared for wider use by the N

News

New metric predicts burden of participating in trials

After patients enrol in clinical trials, regular assessments and testing – often requiring clinic visits – can become onerous and reduce the chances they will stick with t

News

RNA blood test may predict antidepressant response

Selective serotonin reuptake inhibitors (SSRIs) are the first-line drug therapy of choice for most people suffering from depression but often fail to work effectively.

News

Pfizer pauses DMD gene therapy trial after boy’s death

The death of a young boy with Duchenne muscular dystrophy (DMD) who was treated with Pfizer’s experimental gene therapy in a phase 2 trial has prompted the company to paus

News

Sorcero GenAI conjures plain language from scientific papers

Understanding complex scientific studies is often a challenge for patients as well as healthcare professionals, but one that may become easier thanks to artificial intelli

News

Double ApoE4 gene a 'distinct form' of early Alzheimer’s

Having two copies of the ApoE4 gene is not just a risk factor for the development of Alzheimer’s, but is a likely cause of the disease, according to researchers in Spain.

NICE backs wider tumour profiling use in early breast cancer

New metric predicts burden of participating in trials

RNA blood test may predict antidepressant response

Pfizer pauses DMD gene therapy trial after boy’s death

Sorcero GenAI conjures plain language from scientific papers

Double ApoE4 gene a 'distinct form' of early Alzheimer’s

Amazon puts $100m into global health drive

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks